Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Long

Thoracic Surgery (Cardiothoracic Vascular Surgery) Oklahoma City, OK Medical Doctor

NPI 1518906742 CMS profile 114516

3400 Nw Expressway, Suite 200, Oklahoma City, OK 73112

Open in the dashboard

General payments

$633,633

75 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$209,954 paid to institutions, not to them · program years 2019–2024

Through program year 2025, James Long of Oklahoma City, OK is reported in the CMS Open Payments database as having received $633,633 across 75 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $209,954 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $195,000 1
2024 General $391,336 10
2023 General $13 1
2022 General $1,371 11
2021 General $47 3
2020 General $411 11
2019 General $45,455 38

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Long
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to James Long were reported at $195,000. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year James Long Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $45,455 $886 $178–$3,167 $163
2020 $411 $341 $108–$1,605 $114
2021 $47 $453 $125–$1,886 $132
2022 $1,371 $695 $180–$2,566 $149
2023 $13 $745 $205–$2,662 $160
2024 $391,336 $799 $214–$2,967 $164
2025 $195,000 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. BrioHealth Solutions, Inc. $586,071 2 payments
  2. Abbott Laboratories $46,518 40 payments
  3. W. L. Gore & Associates, Inc. $241 3 payments
  4. Allergan Inc. $218 13 payments
  5. Abiomed $193 7 payments
  6. Boston Scientific Corporation $119 1 payment
  7. Medtronic Vascular, Inc. $101 1 payment
  8. Endologix, Inc. $73 2 payments
  9. AbbVie, Inc. $57 3 payments
  10. Medtronic, Inc. $29 2 payments
  11. Other $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $623,871 18 payments
  2. Travel and Lodging $7,485 9 payments
  3. Food and Beverage $2,277 48 payments
Products named General payments · program years 2019–2025
  1. BRIOVAD $586,071 2 payments
  2. HeartMate $24,147 10 payments
  3. HeartMate 3 Left Ventricular Dev $16,800 17 payments
  4. CardioMEMS HF System $4,050 2 payments
  5. THORATEC HEARTMATE 3 LVAS IMPLANT KIT $1,321 8 payments
  6. Product in Development $241 3 payments
  7. Impella $193 7 payments
  8. HeartMate Touch $181 1 payment
  9. VRAYLAR $157 9 payments
  10. WATCHMAN $119 1 payment
  11. Other $430 17 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

75 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record